RDM researchers collaborate on postpartum blood pressure self-monitoring trial in the US
18 December 2024
Researchers in RDM’s Cardiovascular Clinical Research Facility (CCRF) will collaborate with the University of Pennsylvania on a new trial to understand the potential benefits of postpartum blood pressure monitoring in the US healthcare system.
Researchers provide a perspective on mapping the bone marrow using new spatial transcriptomic technologies
13 December 2024
RDM researchers have outlined the potential benefits and limitations of new spatial transcriptomic technologies for mapping the bone marrow in patients with blood cancer.
Support for RDM research in diagnosing and managing heart failure
13 December 2024
The Kusuma Trust has made an award of £400K to fund research in diagnosing and managing heart failure.
New MRC Centre to create cutting-edge gene therapies
11 December 2024
Professor Deborah Gill is to co-lead an MRC research centre being launched to develop new advanced treatments for currently untreatable diseases.
RDM Careers Day showcases a variety of career paths in and beyond academia
9 December 2024
On Thursday 28 November the RDM Careers Day 2024 took place at Magdalen College with almost 80 delegates from across the Department.
Renewal of the Novo Nordisk – University of Oxford Fellowship Programme
2 December 2024
Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.
Davis Group receives Wellcome Discovery Award
2 December 2024
Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled “Small contacts, big decisions – early signal processing by T cells”. This has been awarded jointly with Professor Anna Lippert of the University of Würzburg.
RDM researcher receives award for research shedding light on microstructural and metabolic differences in hypertrophic cardiomyopathy patients
26 November 2024
Congratulations to Dr Zakariye Ashkir who received the Best Scientific Abstract Award from the Association of Inherited Cardiac Conditions at their Annual Conference held in Cambridge earlier this month.
RDM researchers at IF Oxford Science and Ideas Festival
19 November 2024
Researchers from RDM’s Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and the MRC Weatherall Institute of Molecular Medicine (WIMM) took centre stage at this year's IF Oxford Science and Ideas Festival with some exciting and interactive public engagement activities.
Peruvian interns gain invaluable research experience in RDM
18 November 2024
Two interns who have recently graduated from the Research Experience for Peruvian Undergraduates (REPU) have described how their experience of working alongside RDM researchers has opened doors to new opportunities.
Transformative treatments for children with fatal genetic lung diseases
15 November 2024
AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.
Launch of the new BHF Oxford Centre of Research Excellence
14 November 2024
Celebrating a £5million British Heart Foundation renewal award to the University of Oxford to advance cardiovascular science.
Under-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population
24 October 2024
People diagnosed with type 2 diabetes before 40 years of age, have nearly four times the risk of death compared with the general UK population, a new study carried out at the University of Oxford’s Radcliffe Department of Medicine has found.
35 Years of the MRC WIMM
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs
22 October 2024
Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.
Professor Robin Choudhury publishes a new book about the heart
17 October 2024
Robin Choudhury, Professor of Cardiovascular Medicine, has written a book about the art and science of the heart. Here he answers some questions about the origins and highlights of the project.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
Researchers develop new tool to better predict acute myeloid leukaemia outcomes in older patients
17 September 2024
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.